An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer
An Exercise Randomized Controlled Trial Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancer
1 other identifier
interventional
213
1 country
1
Brief Summary
Among African-American women, in whom metabolic syndrome (MetS) is very prevalent and breast cancer mortality rates are high, it is hypothesized that intervening on MetS to improve the MetS profile may prove to be a means to reduce breast cancer risk. Specific recommendations for breast cancer prevention are now focused on maintaining a healthy weight via increased physical activity levels, and losing weight if overweight or obese. This pilot project compares two exercise interventions: a supervised facility-based and a home-based exercise intervention to a control group in African-American women with metabolic syndrome who are at high risk for breast cancer. This study is a 6-month three-arm RCT to assess the impact of the exercise interventions on biomarkers related to obesity, insulin-related pathways, inflammation, hormones, and micro-RNAs. The specific aim of the proposed study is to compare the impact of a supervised facility-based and a home-based exercise intervention on obesity, metabolic syndrome and known breast cancer biomarkers in postmenopausal African-American women with metabolic syndrome who are at increased risk of breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
April 1, 2014
CompletedFirst Posted
Study publicly available on registry
April 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedFebruary 20, 2024
February 1, 2024
11.7 years
April 1, 2014
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Waist circumference
Reduction in waist circumference
6 months
Body Mass Index
Reduction in body mass index
6 months
Biomarkers of breast cancer risk - biomarkers of inflammation
Serum IL-6, TNF-alpha, High sensitivity CRP
6 months
Biomarkers of breast cancer risk - biomarkers of insulin pathway
Fasting glucose, seruminsulin, IGF-1, IGFBP-3
6 months
Biomarkers of breast cancer risk - adipokines
Serum leptin and adiponectin
6 months
Metabolic syndrome
Greater improvements in metabolic syndrome and metabolic syndrome components
6 months
Secondary Outcomes (3)
Cardiorespiratory fitness
6 months
Body composition
6 months
Health-related Quality of Life
6 months
Study Arms (3)
Facility-Based Exercise Intervention
EXPERIMENTALSupervised Facility-Based Exercise Intervention Arm The participants randomized to the exercise group will be required to meet and maintain a goal of 150 min/wk of moderate intensity exercise for 6 months. This intervention will use heart rate and rating of perceived exertion (RPE) to define moderate intensity. Participants will exercise for the prescribed duration at a heart rate in the range of 45-65% of their maximal oxygen consumption (VO2 max), as determined during baseline testing, and with an RPE in the range of 11-14 on the 20-point scale. The exercise will primarily utilize treadmills and exercise bikes.
Control
NO INTERVENTIONAfter baseline testing, the control group will be asked to maintain their current daily activities and exercise habits for the duration of the study (6 months). The control group will have measurements at the same time periods as the participants in the intervention arm through the completion of the study. Participants will be seen for follow-up at 3 and 6 months (study completion). The participants in the control group will receive the same incentives as those in the intervention arms (gift cards). Since the women in the control group are obese, with components of metabolic syndrome, and at relatively high risk for breast cancer, we are providing healthy lifestyle information to the group, via text messages.
Home-Based Exercise Intervention
EXPERIMENTALHome-Based Exercise Intervention Group The participants randomized to this intervention arm will be required to meet and maintain a goal of 150 min/wk of moderate intensity exercise for 6 months, the same as the supervised intervention group. Their exercise goal will be to achieve a total of 10,000 steps per day, as measured by pedometers. Participants will be required to have a cell phone with text messaging capabilities.
Interventions
Supervised Facility-Based Exercise Intervention Arm The participants randomized to the exercise group will be required to meet and maintain a goal of 150 min/wk of moderate intensity exercise for 6 months. This intervention will use heart rate and rating of perceived exertion (RPE) to define moderate intensity. Participants will exercise for the prescribed duration at a heart rate in the range of 45-65% of their maximal oxygen consumption (VO2 max), as determined during baseline testing, and with an RPE in the range of 11-14 on the 20-point scale. The exercise will primarily utilize treadmills and exercise bikes.
Home-Based Exercise Intervention Group The participants randomized to this intervention arm will be required to meet and maintain a goal of 150 min/wk of moderate intensity exercise for 6 months, the same as the supervised intervention group. Their exercise goal will be to achieve a total of 10,000 steps per day, as measured by pedometers. Participants will be required to have a cell phone with text messaging capabilities.
Eligibility Criteria
You may qualify if:
- Eligible participants should be female, African-American postmenopausal women between the ages of 45 and 65 with waist circumference greater than 35 inches (88 cm), 5-year invasive breast cancer risk is greater than 1.40% using the CARE model, and have at least one of the following:
- elevated fasting glucose is greater than or equal to 100 mg/dL
- elevated blood pressure is greater than or equal to 130/85 mm/Hg. In addition, they should also have a cell phone with texting capabilities, read and speak English, reside in close proximity to, or can access the Navy Yard stop on the green line, can provide meaningful consent, and medical clearance from a physician or nurse practitioner.
You may not qualify if:
- physical limitations that prevent participant from exercising
- premenopausal
- pregnant or planning to become pregnant within the next year
- history of cancer (except for non-melanoma skin cancer)
- have diabetes
- use anti-diabetic medication (including insulin)
- are currently enrolled in a physical activity and/or dietary clinical trial
- are on a weight loss program
- cannot commit to the intervention schedule
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Georgetown Lombardi Office of Minority Health community site
Washington D.C., District of Columbia, 20003, United States
Related Publications (2)
Adams-Campbell LL, Taylor T, Hicks J, Lu J, Dash C. The Effect of a 6-Month Exercise Intervention Trial on Allostatic Load in Black Women at Increased Risk for Breast Cancer: the FIERCE Study. J Racial Ethn Health Disparities. 2022 Oct;9(5):2063-2069. doi: 10.1007/s40615-021-01145-x. Epub 2021 Sep 27.
PMID: 34580826DERIVEDDash C, Makambi K, Wallington SF, Sheppard V, Taylor TR, Hicks JS, Adams-Campbell LL. An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods. Contemp Clin Trials. 2015 Jul;43:33-8. doi: 10.1016/j.cct.2015.04.015. Epub 2015 May 8.
PMID: 25962889DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2014
First Posted
April 3, 2014
Study Start
January 1, 2012
Primary Completion
September 1, 2023
Study Completion
December 1, 2025
Last Updated
February 20, 2024
Record last verified: 2024-02